Recce Pharmaceuticals advances US Army burn wound program and Indonesia Phase 3 trial in March...
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)Â has reported Q3 FY2026 operational progress across its anti-infective pipeline, led by a second US Army...
proactiveinvestors.com.au